![]() |
市场调查报告书
商品编码
1828142
2025年全球直线加速器设备市场报告LINAC Devices Global Market Report 2025 |
近年来,直线加速器市场规模强劲成长,从2024年的51亿美元增加至2025年的54.8亿美元,复合年增长率为7.4%。这段时期的成长得益于治疗速度、标准化和监管的进步、放射线手术和立体定位放射线手术的发展、安全性能的增强以及影像整合的改进。
预计未来几年直线加速器设备市场规模将强劲成长,到2029年将达到77.4亿美元,复合年增长率为9.0%。预测期内的增长可归因于癌症发病率的上升、自适应放射治疗的发展、对影像导航放射治疗(IGRT) 的需求不断增长、安全性和患者舒适度的提升以及人工智慧 (AI) 的整合。预测期内的主要趋势包括创新软体解决方案、自适应放射治疗的发展、远端医疗整合、行为管理的融入以及对以患者为中心的护理的重视。
Linac 是直线加速器的缩写,指的是一种用于直线加速电子和质子等带电粒子的装置。在医疗实践中,直线加速器用于产生高能量电子束和 X 射线束,用于放射治疗,尤其是癌症治疗。
直线加速器主要分为高能、低能、中能三种。高能量线性加速器(LINAC) 的工作能量范围为 2,000 万至 5,000 万电子伏特 (MeV)。它们用于产生高能量 X 射线和电子束,用于放射治疗,特别适用于治疗体内深层肿瘤。直线加速器和非专用直线加速器可用于治疗多种癌症,包括乳癌、结肠癌、头颈癌、肺癌和摄护腺癌。这些机器广泛应用于诊所、医院和研究中心。
2025年春季,美国关税飙升及其引发的贸易摩擦对医疗设备产业产生了重大影响,尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场准入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供直线加速器设备市场统计数据,例如全球市场规模、区域份额、直线加速器设备市场份额的竞争对手、详细的直线加速器设备细分市场、市场趋势以及直线加速器设备行业的商机。本直线加速器设备市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
未来五年预测成长率为9.0%,较我们先前对该市场的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这将透过对荷兰和巴西等关键地区生产的微波发生器和多叶准直器征收关税直接影响美国,这可能导致癌症治疗推迟,并增加放射治疗设备的维护成本。此外,由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响,这种影响也将更加广泛地显现。
癌症患者数量的预期成长将推动直线加速器设备市场的成长。癌症的特征是细胞生长失控以及体内异常细胞的扩散,放射治疗中使用直线加速器 (LINAC) 进行治疗。这些机器将高能量X射线从外部来源发射到癌症部位,以治疗各种癌症。值得注意的是,根据美国癌症协会截至2023年1月的数据,预计癌症患者数量将从2021年的1,898,160人增加3.16%,到2023年将达到1,958,310人。因此,癌症患者数量的成长是推动直线加速器设备市场发展的关键因素。
不断增长的医疗支出推动了直线加速器设备市场的成长。医疗支出是指特定时限内医疗产品和服务的总支出,包括使用直线加速器设备进行先进肿瘤治疗的相关费用。例如,加拿大卫生资讯研究所 (CIHI) 于 2022 年 11 月发布的预测显示,加拿大的医疗总支出将增加 0.8%,从 2021 年的 3,280 亿美元增至 2022 年的 3,310 亿美元。医疗支出的这种上升趋势是直线加速器设备市场发展的驱动力。
技术进步正成为直线加速器设备市场的显着趋势,主要企业纷纷推出创新产品,例如ViewRay MRIdian MRI导引放射治疗系统,以维持其市场地位。 2023年3月,美国癌症和心臟护理提供者GenesisCare在Lee Health Regional Cancer Center推出了MRI导引放射治疗系统。 MRIdian系统将高精度放射治疗与尖端高解析度MRI导引相结合,可望减少所需的治疗次数。这项以MRIdian立体定位MRI引导自适应放射治疗(SMART)为代表的技术创新,代表了直线加速器设备市场的重要趋势。
直线加速器设备市场的主要参与者正专注于开发先进技术,例如基于人工智慧的自适应 CT-Linac 系统,以提高治疗准确性、优化放射输送并改善癌症治疗中的患者预后。基于人工智慧的自我调整CT-Linac 是一种先进的放射治疗系统,结合了电脑断层扫描 (CT) 成像和直线加速器 (linac) 技术。它利用人工智慧即时调整治疗计划,提高精度并改善患者预后。例如,2024 年 5 月,总部位于瑞典的精准放射治疗解决方案领导者 Elekta 推出了 Elekta Evo。这款最先进的直线加速器 (linac) 专为癌症治疗而设计,拥有高清、人工智慧增强影像处理能力,可实现离线和线上自适应放射治疗。这种灵活的系统使临床医生能够根据每位患者的独特需求选择最有效的放射治疗技术,从而提高标靶准确性并最大限度地减少副作用。 Evo 内建治疗计画自动化功能,可提高工作流程效率并促进放射肿瘤学的个人化治疗。
2023年11月,荷兰磁控管和晶闸管製造商AEP Linac与Arcare达成合作,以增强其放射治疗解决方案,合作金额不详。 AEP Linac是一家生产用于(医用)直线加速器的磁控管和闸流管的製造商。此次合作旨在整合Arcare在患者照护产品方面的专业知识,并增强AEP Linac的产品线,最终改善整体治疗体验。 Arcare是一家总部位于日本的公司,以其创新的解决方案而闻名,这些解决方案优先考虑患者在医疗环境中的舒适度和復原力。
直线加速器设备市场的主要参与者包括 Accuracy Inc.、Elekta AB、GE Healthcare Technologies Inc.、Hitachi, Ltd.、Huiheng Medical Inc.、Koninklijke Philips NV、Mitsubishi Heavy Industries, Ltd.、Top Grade Healthcare Group、Varian Medical Systems Inc.、Siemens Healthine Healthine Gmb. GmbH、工业, Ltd.、ProNova Solutions LLC、RaySearch Laboratories AB、P-Cureapcm. Inc.、Nanobiotix SA、C-RAD AB、Theragenics Corporation、Isoray Inc. 和 Nordion Inc.
2024年,北美是直线加速器设备市场最大的地区。预计亚太地区将成为预测期内全球直线加速器设备市场成长最快的地区。直线加速器设备市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。
直线加速器设备市场报告涵盖的国家包括澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙
直线加速器设备市场包括电子生成组件、光束传输设备、放射治疗设备以及成像和监测配件的销售。该市场的价值指的是“出厂价”,即商品製造商或生产商销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。
LINAC stands for linear accelerator, and it refers to a device designed to accelerate charged particles, such as electrons or protons, in a straight line. In medical settings, LINACs are utilized to generate high-energy electron or X-ray beams for radiation therapy, specifically in the treatment of cancer.
The main products of LINAC devices include high-energy, low-energy, and medium-energy devices. A high-energy linear accelerator (LINAC) operates at energies ranging from 20 to 50 million electron volts (MeV). It is used to produce high-energy X-rays or electron beams for radiation therapy, particularly for treating tumors located deep within the body. Linear accelerator and non-dedicated linear accelerator methods are employed in the treatment of various cancers such as breast cancer, colorectal cancer, head and neck cancer, lung cancer, prostate cancer, and others. These devices find application in clinics, hospitals, and research centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The LINAC devices market research report is one of a series of new reports from The Business Research Company that provides LINAC devices market statistics, including the LINAC devices industry global market size, regional shares, competitors with a LINAC devices market share, detailed LINAC devices market segments, market trends, and opportunities, and any further data you may need to thrive in the LINAC devices industry. This LINAC devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The linac devices market size has grown strongly in recent years. It will grow from $5.1 billion in 2024 to $5.48 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to advancements in treatment delivery speed, standardization and regulation, growth in radiosurgery and stereotactic radiosurgery, enhanced safety features, improvements in imaging integration.
The linac devices market size is expected to see strong growth in the next few years. It will grow to $7.74 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to rise in cancer incidences, development of adaptive radiotherapy, increasing demand for image-guided radiation therapy (IGRT), enhanced safety and patient comfort, integration of artificial intelligence (AI). Major trends in the forecast period include innovative software solutions, adaptive radiotherapy development, telemedicine integration, incorporation of motion management, focus on patient-centric care.
The forecast of 9.0% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on microwave power generators and multi-leaf collimators, sourced from key regions such as the Netherlands and Brazil, which could lead to postponed cancer treatments and increased costs for radiation therapy equipment maintenance.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated increase in cancer cases is set to drive the growth of the LINAC devices market. Cancer, characterized by uncontrolled cell growth and the spread of abnormal cells within the body, is a target for treatment using Linear Accelerators (LINAC) in radiation therapy. These devices deliver high-energy X-rays externally to the cancer site to treat various forms of cancer. Notably, data from the American Cancer Society in January 2023 indicates a rise in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, marking a 3.16% growth. Consequently, the growing number of cancer cases is a significant factor propelling the LINAC devices market.
The increasing healthcare expenditure is poised to contribute to the growth of the LINAC devices market. Healthcare expenditure, representing the total financial outlay on healthcare goods and services within a specific timeframe, encompasses the costs associated with advanced oncology treatments using Linear Accelerator (LINAC) devices. For example, projections from the Canadian Institute for Health Information (CIHI) in November 2022 forecast a 0.8% increase in total health spending in Canada, from $328 billion in 2021 to $331 billion in 2022. This upward trend in healthcare expenditure is a driving force behind the LINAC devices market.
Technological advancements emerge as a prominent trend in the LINAC devices market, with major companies introducing innovative products such as the ViewRay MRIdian MRI-Guided Radiation Therapy System to maintain their market position. In March 2023, GenesisCare, a US-based provider of cancer and cardiac care, launched an MRI-guided radiation therapy system at the Lee Health Regional Cancer Center. The MRIdian system combines precision radiation therapy with state-of-the-art, high-resolution MRI guidance, potentially reducing the number of treatment sessions required. This technological innovation, exemplified by MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) therapy, marks a significant trend in the LINAC devices market.
Key players in the LINAC devices market are focusing on the development of advanced technologies, including AI-powered adaptive CT-Linac systems, to improve treatment accuracy, optimize radiation delivery, and enhance patient outcomes in cancer therapy. An AI-powered adaptive CT-Linac is a sophisticated radiation therapy system that merges computed tomography (CT) imaging with linear accelerator (LINAC) technology, employing artificial intelligence to adjust treatment plans in real time for better precision and improved patient results. For example, in May 2024, Elekta, a Sweden-based leader in precision radiation therapy solutions, introduced Elekta Evo. This state-of-the-art linear accelerator (LINAC) is designed for cancer treatment and boasts high-definition AI-enhanced imaging capabilities, enabling both offline and online adaptive radiation therapy. The flexible system empowers clinicians to choose the most effective radiation therapy techniques tailored to each patient's unique needs, thereby enhancing targeting accuracy and minimizing side effects. With built-in automation for treatment planning, Evo improves workflow efficiency and promotes personalized care in radiation oncology.
In November 2023, AEP Linac, a Netherlands-based manufacturer of magnetrons and thyratrons utilized in (medical) linear accelerators, formed a partnership with Alcare for an undisclosed amount to strengthen its radiation therapy solutions. This collaboration aims to enhance AEP Linac's product offerings by integrating Alcare's expertise in patient care products, ultimately improving the overall treatment experience. Alcare is a Japan-based company known for its innovative solutions that prioritize patient comfort and recovery in medical environments.
Major companies operating in the LINAC devices market include Accuracy Inc., Elekta AB, GE Healthcare Technologies Inc., Hitachi Ltd., Huiheng Medical Inc., Koninklijke Philips N.V., Mitsubishi Heavy Industries Ltd., Top Grade Healthcare Group, Varian Medical Systems Inc., Siemens Healthineers GmbH, Shinva Medical Instrument Co. Ltd., Altair Technologies Inc., BEVATECH GmbH, CGN Dasheng Electron Accelerator Technology Company Limited, Diondo GmbH, IBA SA, Brainlab AG, Panacea Medical Technologies Pvt. Ltd., Viewray Technologies Inc., MeVion Medical Systems Inc., Sumitomo Heavy Industries Ltd., ProNova Solutions LLC, RaySearch Laboratories AB, P-Cure Ltd., Best Theratronics Ltd., Advanced Oncotherapy PLC, RefleXion Medical Inc., Nanobiotix S A, C-RAD AB, Theragenics Corporation, Isoray Inc., Nordion Inc.
North America was the largest region in the LINAC devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global LINAC devices market report during the forecast period. The regions covered in the linac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the linac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The LINAC devices market consists of sales of an electron generation component, beam transport equipment, radiotherapy equipment, imaging and monitoring accessory. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
LINAC Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on linac devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for linac devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The linac devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.